Back to Search Start Over

Following the chosen path: the Swiss pharmaceutical industry is continuing to follow its traditional vein of innovation, although increases in r&d costs and validation requirements could threaten future projects

Authors :
Shine, Ian
Source :
Manufacturing Chemist. June, 2005, Vol. 76 Issue 6, p37, 3 p.
Publication Year :
2005

Details

Language :
English
ISSN :
02624230
Volume :
76
Issue :
6
Database :
Gale General OneFile
Journal :
Manufacturing Chemist
Publication Type :
Periodical
Accession number :
edsgcl.134163461